DEBACTEROL® has been used for
decades in the United States for the treatment of a variety of
ulcerating lesions and minor trauma of the oral mucosa. As a
semi-viscous liquid, DEBACTEROL® has surface tension properties
that enable very small quantities of the material to adhere tightly to
the surface of common dental and medical instruments for carefully
limited applications. DEBACTEROL® can be applied in larger
quantities through the use of cotton swabs dipped in the product. Even
larger amounts are commonly layered into necrotic areas using a syringe
and blunt needle. The combination of physical characteristics, the
dark-brown color and intense denaturant activity allows for very
precise treatement of any size or type of lesion in virtually any area
of the oral cavity.
By far the
most frequent indication for DEBACTEROL® is in the treatment of
Recurrent Aphthous Stomatitis (RAS). Aphthous Stomatitis (also known as
Aphthous Ulcers, or, Canker Sores) is the most common disorder of the
mouth.
In the United States Aphthous Stomatitis has been
reported to be found in 15% to 65% of various population subgroups with
a prevalence rate of approximately 20% overall. Data published by the
WHO and other public health institutions shows that overall prevalence
rates in developed countries range from 20 - 25%, but in some heavily
populated underdeveloped countries of Asia, Africa and South America,
prevalence rates are as high as 50%.
Some of the most difficult mouth ulcers to manage are
those that occur in patients with an underlying systemic illness. Many
systemic diseases, and their treatments, can severely limit the body's
own natural healing capabilities, while the pain of persistent oral
ulcers aggravates problems with eating and drinking. For example,
frequent RAS-like lesions are a well known complication of AIDS. In
addition, oncology patients receiving cytotoxic therapy are also known
to develop severe intractable stomatitis as a side effect of their
treatment. Patients who are chronically disabled for a variety of
reasons, physical and mental, are known to develop ulcerating oral
lesions because their disability leads to poor dental health habits.
There are no comprehensive and definitive studies on the
prevalence of all of the varieties of ulcerating oral lesions
worldwide. However, it is certainly possible to infer from the
information found in a number of sample surveys that, at any point in
time, from 30% to 40% of the world's population suffers from periodic
ulcerating oral lesions of one kind or another.
Copyright
©2023 Terms of Use
All Rights Reserved
|